- Carraro, Gianni;
- Langerman, Justin;
- Sabri, Shan;
- Lorenzana, Zareeb;
- Purkayastha, Arunima;
- Zhang, Guangzhu;
- Konda, Bindu;
- Aros, Cody J;
- Calvert, Ben A;
- Szymaniak, Aleks;
- Wilson, Emily;
- Mulligan, Michael;
- Bhatt, Priyanka;
- Lu, Junjie;
- Vijayaraj, Preethi;
- Yao, Changfu;
- Shia, David W;
- Lund, Andrew J;
- Israely, Edo;
- Rickabaugh, Tammy M;
- Ernst, Jason;
- Mense, Martin;
- Randell, Scott H;
- Vladar, Eszter K;
- Ryan, Amy L;
- Plath, Kathrin;
- Mahoney, John E;
- Stripp, Barry R;
- Gomperts, Brigitte N
Cystic fibrosis (CF) is a lethal autosomal recessive disorder that afflicts more than 70,000 people. People with CF experience multi-organ dysfunction resulting from aberrant electrolyte transport across polarized epithelia due to mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CF-related lung disease is by far the most important determinant of morbidity and mortality. Here we report results from a multi-institute consortium in which single-cell transcriptomics were applied to define disease-related changes by comparing the proximal airway of CF donors (n = 19) undergoing transplantation for end-stage lung disease with that of previously healthy lung donors (n = 19). Disease-dependent differences observed include an overabundance of epithelial cells transitioning to specialized ciliated and secretory cell subsets coupled with an unexpected decrease in cycling basal cells. Our study yields a molecular atlas of the proximal airway epithelium that will provide insights for the development of new targeted therapies for CF airway disease.